ZAFIRLUKAST

Generic: ZAFIRLUKAST

Aurobindo Pharma LimitedManufacturer
ORALRoute
ZAFIRLUKASTActive Substance
2023-11-27Original Approval

ZAFIRLUKAST is FDA application ANDA213163, sponsored by AUROBINDO PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DYSPNOEA
110 reports
2
ASTHMA
96 reports
3
FATIGUE
87 reports
4
DRUG INEFFECTIVE
65 reports
5
COUGH
56 reports
6
NAUSEA
51 reports
7
PRURITUS
49 reports
8
OFF LABEL USE
48 reports
9
WHEEZING
48 reports
10
HEADACHE
47 reports